drugset / Trial / NCT01470664

FST-100 in the Treatment of Acute Adenoviral Conjunctivitis

NCT01470664 ↗

Phase 2 Completed 176 enrolled Shire
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This randomized, double masked, multi-center study is being conducted to support the safety and efficacy of FST-100 for the treatment of acute adenoviral conjunctivitis.

Timeline

Start
2012-12-17
Primary completion
2014-05-23
Completion
2014-05-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.1 % Other
Subject polyvinylpyrrolidone iodine Unknown 0.6 % Other

Indications